Metabometrix ltd

Metabometrix Ltd is a spin-out company founded in 2000 on the skills and expertise of the world-leading metabonomics research team at Imperial College London and chaired by the eminent scientist and business man, Sir Richard Sykes.

The whole field of metabonomics has been pioneered over 25 years by a ground-breaking group of scientists led by Professor Jeremy Nicholson, Professor John  Lindon and Professor Elaine Holme. A whole range of unique analytical and data processing developments have been achieved, and these, together with an unparalleled set of application areas, underpin a continuing substantial lead in the field.

Metabonomics characterises the key biochemical changes caused by a range of interventions and conditions, such as drug toxicity in animals and man, the diagnosis and course of clinical disease, the effects of therapeutic intervention and the impact of nutrition and life-style changes. The approach has the potential to impact strongly on drug discovery and development from lead molecule selection to marketing of clinically successful drugs. Metabometrix Ltd has successfully completed projects across this wide range of biomedical applications for both industrial and academic clients.

In addition to its own intrinsic power, metabonomics is a key driver for integrating knowledge at all of the levels of molecular biology to provide a true top-down systems biology understanding, and Metabometrix Ltd, with its in-house expertise, is well placed to exploit this unique advantage.

The company is conveniently located in central London in the state-of- the-art Imperial Incubator on the Imperial College London, South Kensington campus. It also has modern, advanced analytical technology and sophisticated data processing and statistics tools for generating data and providing interpretation